Convatec Group PLC (CTEC)

Industry Medical Instruments & Supplies


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

220.40p

Buy

220.60p

arrow-up0.40p (+0.18%)

Prices updated at 02 Apr 2026, 17:15 BST
| Prices minimum 15 mins delay
|
Prices in GBX

ConvaTec Group PLC is a medical products and technologies company focused on therapies for the management of chronic conditions offering wound care, ostomy care, continence and critical care, and infusion devices.

Income statement

20242025
2,289m2,439m
1,284m1,371m
332m386m
14.5015.83
191m175m
541m516m
Sales, General and administrative840m874m
Interest expenses74m62m
Provision for income taxes55m55m
Operating expenses952m985m
Income before taxes246m230m
Net income available to common shareholders191m175m
0.0930.086
Net interest income-78m-68m
Advertising and promotion--
Net investment income, net-18m32m
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)0.0930.086
Free cash flow per share0.09980.1219
Book value/share0.64510.6882
Debt equity ratio0.6986380.982872

Balance sheet

20242025
Current assets793m940m
Current liabilities512m616m
Total capital2,812m2,916m
Total debt1,202m1,518m
Total equity1,689m1,518m
Total non current liabilities--
Loans1,123m1,398m
Total assets3,515m3,781m
Total liabilities--
Cash and cash equivalents65m68m
Common stock2,044m1,954m

Cash flow

20242025
Cash at beginning of period98m65m
Cash dividends paid-130m-140m
274m285m
Investments (gains) losses-161m-208m
65m68m
Net income--
396m470m
-122m-185m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.